16 results
8-K
EX-2.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
(a)
Plan
Section 3.11(a)
Privacy Requirements
Section 3.14(h)(i)
Privacy/Data Security Laws
Section 9.03
Protected Health Information
Section 9.03
Reference … a Company Material Adverse Effect, the Company (i) currently and previously has complied with all applicable Privacy/Data Security Laws and the Company’s
425
EX-2.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Sep 23
Business combination disclosure
4:28pm
(a)
Plan
Section 3.11(a)
Privacy Requirements
Section 3.14(h)(i)
Privacy/Data Security Laws
Section 9.03
Protected Health Information
Section 9.03
Reference … a Company Material Adverse Effect, the Company (i) currently and previously has complied with all applicable Privacy/Data Security Laws and the Company’s
S-4/A
2vy94nf9r mkjxc
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
S-4
120hh7f
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
424B3
j8tmps9k
21 Nov 23
Prospectus supplement
9:15am
424B4
hsv0xv6
11 Dec 20
Prospectus supplement with pricing info
12:00am
424B4
uil7w6ncou
11 Dec 20
Prospectus supplement with pricing info
1:38pm
- Prev
- 1
- Next